Patents by Inventor George W. Jackson
George W. Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240110237Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules.Type: ApplicationFiled: July 28, 2023Publication date: April 4, 2024Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor, Alexander Chiu
-
Patent number: 11725240Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid derivatives.Type: GrantFiled: January 19, 2021Date of Patent: August 15, 2023Assignee: BASE PAIR BIOTECHNOLOGIES, INC.Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor, Alexander Chiu
-
Publication number: 20230217932Abstract: This invention relates generally to methods of preparing compositions from microorganisms such as cyanobacteria, particularly to preparing compositions with antifungal and/or antibacterial characteristics, and more particularly to preparing cyanobacteria or other microorganism-derived compositions for use in construction materials. Cyanobacteria make various kinds of natural products that may be useful for a variety of applications, including products with antifungal and/or antibacterial activity, and other biologically active compounds (e.g. immunomodulatory, antitumor, antithrombotic, anticoagulant, anti-mutagenic, anti-inflammatory, antimicrobial, and antiviral). Some of the especially useful ones might be antifungals and antibacterials, such as by incorporation or application onto construction materials (e.g. drywall).Type: ApplicationFiled: January 11, 2023Publication date: July 13, 2023Inventor: George W. Jackson
-
Publication number: 20230111624Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as vitamin C or malaria histidine-rich protein II (HRP2).Type: ApplicationFiled: June 20, 2018Publication date: April 13, 2023Inventor: George W. Jackson
-
Patent number: 11608356Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as antibiotics, such as colistin.Type: GrantFiled: February 22, 2020Date of Patent: March 21, 2023Assignee: BASE PAIR BIOTECHNOLOGIES, INC.Inventors: Robert Batchelor, George W. Jackson, Truong Nguyen, Vinoth Sankarapani
-
Patent number: 11427825Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as drug compounds, such as levamisole and cocaine.Type: GrantFiled: February 28, 2018Date of Patent: August 30, 2022Assignee: Base Pair Biotechnologies, Inc.Inventors: George W. Jackson, Robert Batchelor, Truong Nguyen, Rafal Drabek, Alexander S. Chiu, Deepak Thirunavukarasu, Vinoth Sankarapani
-
Publication number: 20210395920Abstract: This invention relates to methods and materials for multiplexed utilization of collections of functional ligands, particularly to methods and materials for selecting for and/or utilizing particular desirable traits of functional ligands in a multiplexed manner, and more particularly to methods and materials for selecting for and/or utilizing particular structural changes of functional ligands in a multiplexed manner.Type: ApplicationFiled: August 30, 2021Publication date: December 23, 2021Inventors: George W. Jackson, Robert Batchelor, Alexander S. Chiu, Rafal Drabek, Deepak Thirunavukarasu, Caitlin Bruns
-
Publication number: 20210348226Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid derivatives.Type: ApplicationFiled: January 19, 2021Publication date: November 11, 2021Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor, Alexander Chiu
-
Patent number: 11111603Abstract: This invention relates to methods and materials for multiplexed utilization of collections of functional ligands, particularly to methods and materials for selecting for and/or utilizing particular desirable traits of functional ligands in a multiplexed manner, and more particularly to methods and materials for selecting for and/or utilizing particular structural changes of functional ligands in a multiplexed manner.Type: GrantFiled: January 30, 2019Date of Patent: September 7, 2021Assignee: Base Pair Biotechnologies, Inc.Inventors: George W. Jackson, Robert Batchelor, Alexander S. Chiu, Rafal Drabek, Deepak Thirunavukarasu, Caitlin Bruns
-
Patent number: 11078489Abstract: The present invention relates to methods and compositions for enhancing backscattering interferometry (BSI) in detection of biomolecular interactions, particularly to methods and compositions for enhancing BSI utilizing label-free aptamers, and more particularly to methods and compositions for enhancing BSI utilizing high conformational change aptamers, which may change in conformation when the aptamers bind to their target molecules.Type: GrantFiled: April 23, 2018Date of Patent: August 3, 2021Assignee: Base Pair Biotechnologies, Inc.Inventors: George W. Jackson, Darryl Bornhop
-
Publication number: 20210123056Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as herbicides, such as dicamba.Type: ApplicationFiled: May 3, 2019Publication date: April 29, 2021Inventors: George W. Jackson, Robert Batchelor, Truong Nguyen, Anna Hickey, Caitlin Huddleston, Vinoth Sankarapani
-
Patent number: 10941444Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as lipoarabinomannan (LAM).Type: GrantFiled: January 30, 2019Date of Patent: March 9, 2021Assignee: Base Pair Biotechnologies, Inc.Inventors: George W. Jackson, Robert Batchelor, Rafal Drabek, Caitlin Bruns
-
Patent number: 10927381Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as molecules used proteins or peptides, such as LL37.Type: GrantFiled: November 7, 2019Date of Patent: February 23, 2021Assignee: Base Pair Biotechnologies, Inc.Inventors: George W. Jackson, Robert Batchelor, Truong Nguyen, Victoria Singer, Garam Lee, Rafal Drabek
-
Patent number: 10920228Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as biocide molecules.Type: GrantFiled: January 30, 2019Date of Patent: February 16, 2021Assignee: Base Pair Biotechnologies, Inc.Inventors: George W. Jackson, Robert Batchelor, Alexander S. Chiu, Rafal Drabek, Deepak Thirunavukarasu
-
Publication number: 20210041470Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid metabolites.Type: ApplicationFiled: March 27, 2020Publication date: February 11, 2021Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor
-
Patent number: 10676781Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as tetrahydrocannabinol (THC).Type: GrantFiled: June 12, 2018Date of Patent: June 9, 2020Assignee: Base Pair Biotechnologies, Inc.Inventor: George W. Jackson
-
Publication number: 20200172906Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as molecules used proteins or peptides, such as LL37.Type: ApplicationFiled: November 7, 2019Publication date: June 4, 2020Inventors: George W. Jackson, Robert Batchelor, Truong Nguyen, Victoria Singer, Garam Lee, Rafal Drabek
-
Patent number: 10538770Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules such as chikungunya viral proteins, such as chikungunya envelope protein E1.Type: GrantFiled: September 21, 2017Date of Patent: January 21, 2020Assignee: Base Pair Biotechnologies, Inc.Inventor: George W. Jackson
-
Publication number: 20190382766Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as drug compounds, such as levamisole and cocaine.Type: ApplicationFiled: February 28, 2018Publication date: December 19, 2019Inventors: George W. Jackson, Robert Batchelor, Truong Nguyen, Rafal Drabek, Alexander S. Chiu, Deepak Thirunavukarasu, Vinoth Sankarapani
-
Patent number: 10415041Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as amino acids, such as citrulline, and to target molecules such as crystallin or its subunits, such as alpha crystallin B-chain (CRYAB).Type: GrantFiled: February 9, 2018Date of Patent: September 17, 2019Assignee: Base Pair Biotechnologies, Inc.Inventor: George W. Jackson